Ultrastructural features of danazol-induced cholestasis: A case study

Ultrastructural Pathology

Volumn 20, Issue 5, 1996, Pages 491-495

  Alvaro, Domenico ^a,c   Piat, Claudia ^a   Francia, Chiara ^a   Franchitto, Antonio ^a   Furfaro, Sonia ^a   Valente, Costanzo ^a   Capocaccia, Livio ^a   Gaudio, Eugenio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c NONE   (Italy)

Author keywords

Anabolic steroids; Danazol; Drug induced cholestasis

Indexed keywords

ANABOLIC AGENT; DANAZOL; S ADENOSYLMETHIONINE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CASE REPORT; CHOLESTASIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0029769632     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129609016353     Document Type: Article

References (21)

1. Stein J. Reaction histochimique stable de detection de dosage des pigments biliares dans le sérum sanguin. CR Soc Biol (Paris). 1935;120:1136.
2. Fouchet A. Methode nouvelle de recherce et de dosage des pigments biliares dans le sérum sanguin. CR Soc Biol (Paris). 1917;80:826.
3. Alvaro D, Angelico M, Cantafora A, et al. Improvement of estradiol 17β-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat. Hepatology. 1991;13:1158-1172.
4. Madanes AE, Farber M. Danazol. Ann Intern Med. 1982; 96:625-630.
5. Greenblatt RB, Dmowski WP, Mahesh VB, Scholer HFL. Clinical studies with an antigonadotropin-danazol. Fertil Steril. 1971;22:102-112.
6. Blackmore WP. Danazol in the treatment of benign breast disease. J Int Med Res. 1977;5(suppl 3):101-108.
7. Pitts JS, Donaldson VH, Forristal J, Wyatt RJ. Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the fourth and second components of complement. J Lab Clin Med. 1978;92:501-507.
8. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall RM, So AG. Danazol for the treatment of idiophatic thrombocytopenic purpura. N Engl J Med. 1983;308:1396-1399.
9. Hosea SW, Santaella ML, Brown EJ, Berger M, Katushka K, Frank MM. Long-term therapy of hereditary angioedema with danazol. Ann Intern Med. 1980;93:809-812.
10. Bagheri SA, Boyer JL. Peliosis hepatitis associated with androgenic anabolic steroid therapy: a severe form of hepatic injury. Ann Intern Med. 1984;81:610-618.
11. Nakajima T, Mizushima N, Matsuda H. Fulminant hepatic failure associated with aplastic anemia after treatment with danazol. Br J Obstet Gynaecol. 1986;93:1013-1015.
12. Buamah PK. An apparent danazol-induced primary hepatocellular carcinoma: case report. J Surg Oncol. 1985;28: 114-116.
13. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol. 1990;11:272-276.
14. Zimmermann HJ, Lewis JH. Drug-induced cholestasis. Semin Liver Dis. 1987;7:230-236.
15. King PD, Blitzer BL. Drug-induced cholestasis: pathogenesis and clinical features. Semin Liver Dis. 1990;10:316-321.
16. Xiol X, Martinez-Lacasa J, Pons M, Marti L. Jaundice after danazol therapy for endometriosis. Am J Gastroenterol. 1989;84:834-835.
17. Silva MO, Reddy KR, McDonald T, Jeffers LJ, Schiff ER. Danazol-induced cholestasis. Am J Gastroenterol. 1989;84: 426-428.
18. Qaseem T, Jafri W, Khurshid M, Khan K. Cholestatic jaundice associated with danazol therapy. Postgrad Med J. 1992;68:984-986.
19. Bray GP, Tredger JM, Williams R. Resolution of danazol-induced cholestasis with S-adenosylmethionine. Postgrad Med J. 1993;69:237-239.
20. Pearson K, Zimmerman HJ. Danazol and liver damage. Lancet. 1980;1:645-646.
21. Boue F, Benoit C, Delfraissy JF. Danazol and cholestatic hepatitis. Ann Intern Med. 1986;105:139-140.